Mirjam Christ-Crain Selected Research

Psychogenic Polydipsia

5/2022	Glucagon-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a double-blind, randomized, placebo-controlled study.
1/2022	Effect of a 3-Week Treatment with GLP-1 Receptor Agonists on Vasoactive Hormones in Euvolemic Participants.
10/2021	A randomized controlled trial of the GLP-1 receptor agonist dulaglutide in primary polydipsia.
11/2020	Effects of glucagon-like peptide-1 receptor agonists on fluid intake in healthy volunteers.
1/2020	Effect of Arginine on the Hypothalamic-Pituitary-Adrenal Axis in Individuals With and Without Vasopressin Deficiency.
1/2019	Vasopressin and Copeptin in health and disease.
1/2019	Arginine-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a prospective diagnostic study.
12/2018	FGF-21 levels in polyuria-polydipsia syndrome.
1/2018	Reply to comment on: Sailer CO, et al. Primary polydipsia in the medical and psychiatric patient: characteristics, complications and therapy.
3/2017	Evaluation of copeptin and commonly used laboratory parameters for the differential diagnosis of profound hyponatraemia in hospitalized patients: 'The Co-MED Study'.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mirjam Christ-Crain Research Topics

Disease

50	Pneumonia (Pneumonitis) 01/2022 - 01/2006
26	Respiratory Tract Infections (Respiratory Tract Infection) 01/2018 - 02/2004
25	Infections 11/2021 - 10/2004
20	Sepsis (Septicemia) 01/2018 - 01/2005
19	Inflammation (Inflammations) 06/2022 - 10/2004
18	Hyponatremia 01/2022 - 05/2013
16	Bacterial Infections (Bacterial Infection) 10/2017 - 02/2004
15	Chronic Obstructive Pulmonary Disease (COPD) 01/2018 - 01/2007
14	Stroke (Strokes) 06/2022 - 12/2009
13	Psychogenic Polydipsia 05/2022 - 01/2016
13	Critical Illness (Critically Ill) 01/2019 - 12/2005
12	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2021 - 06/2008
11	Ischemic Stroke 06/2022 - 09/2010
10	Diabetes Insipidus 05/2022 - 07/2007
8	Obesity 01/2022 - 02/2011
8	Insulin Resistance 01/2019 - 06/2008
6	Type 2 Diabetes Mellitus (MODY) 07/2020 - 01/2012
6	Polyuria 05/2020 - 06/2015
6	Hypothyroidism 01/2019 - 02/2003
5	Polydipsia 05/2020 - 06/2015
5	Cushing Syndrome 01/2020 - 06/2008
5	Neurogenic Diabetes Insipidus (Central Diabetes Insipidus) 01/2020 - 01/2016
4	Body Weight (Weight, Body) 01/2022 - 09/2006
4	Fever (Fevers) 08/2021 - 07/2006
4	Bacteremia 01/2019 - 03/2007
4	Septic Shock (Toxic Shock Syndrome) 12/2017 - 08/2007
4	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2016 - 01/2005
3	COVID-19 11/2021 - 07/2020
3	Neoplasms (Cancer) 03/2021 - 04/2019
3	Hypoglycemia (Reactive Hypoglycemia) 12/2020 - 07/2007
3	Nephrogenic Diabetes Insipidus 01/2019 - 01/2018
3	Wounds and Injuries (Trauma) 12/2017 - 09/2008
3	Inappropriate ADH Syndrome (SIADH) 09/2017 - 12/2013
3	Bronchitis 05/2010 - 07/2007
3	Virus Diseases (Viral Diseases) 01/2010 - 01/2005
2	Hypopituitarism (Sheehan's Syndrome) 08/2021 - 04/2019
2	Acromegaly 03/2021 - 04/2019
2	Embolic Stroke 01/2020 - 01/2018
2	Adrenal Insufficiency (Adrenal Gland Hypofunction) 12/2019 - 01/2008
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 07/2019 - 01/2013
2	Pituitary Neoplasms (Pituitary Adenoma) 04/2019 - 01/2013
2	Diabetes Mellitus 01/2018 - 12/2016
2	Chronic Bronchitis 01/2018 - 03/2010
2	Hyperglycemia 01/2018 - 09/2006

Drug/Important Bio-Agent (IBA)

46	ProcalcitoninIBA 01/2020 - 02/2004
40	Biomarkers (Surrogate Marker)IBA 06/2022 - 01/2005
35	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 02/2004
22	C-Reactive ProteinIBA 07/2020 - 02/2003
19	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 01/2008
19	Hydrocortisone (Cortisol)FDA LinkGeneric 11/2021 - 11/2007
16	SodiumIBA 01/2022 - 01/2011
12	Peptides (Polypeptides)IBA 01/2022 - 08/2007
10	GlucocorticoidsIBA 11/2021 - 06/2008
10	ElectrolytesIBA 01/2021 - 05/2013
9	Vasopressins (Vasopressin)IBA 01/2022 - 04/2007
9	Hormones (Hormone)IBA 06/2019 - 06/2008
8	AdrenomedullinIBA 11/2016 - 01/2005
7	Prednisone (Sone)FDA LinkGeneric 11/2021 - 05/2010
7	Adrenocorticotropic Hormone (ACTH)FDA Link 12/2020 - 01/2008
7	Atrial Natriuretic Factor (ANF)IBA 01/2018 - 02/2005
7	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 07/2013 - 02/2004
6	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 12/2009
6	Interleukin-1 (Interleukin 1)IBA 12/2021 - 01/2017
6	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 08/2021 - 01/2017
6	DiureticsIBA 08/2021 - 12/2013
6	Arginine Vasopressin (Argipressin)IBA 10/2020 - 07/2007
6	Natriuretic PeptidesIBA 01/2020 - 01/2010
5	CytokinesIBA 07/2020 - 10/2008
5	Arginine (L-Arginine)FDA Link 01/2020 - 01/2017
5	Testosterone (Sustanon)FDA Link 12/2018 - 01/2012
4	Interleukin-6 (Interleukin 6)IBA 12/2020 - 01/2005
4	Insulin (Novolin)FDA Link 12/2020 - 07/2007
4	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 07/2020 - 01/2018
4	Metformin (Glucophage)FDA LinkGeneric 01/2020 - 06/2008
4	proadrenomedullinIBA 01/2018 - 05/2011
4	EnzymesIBA 12/2017 - 06/2008
4	Pharmaceutical PreparationsIBA 12/2016 - 08/2005
4	Thyroxine (Levothyroxine)FDA LinkGeneric 04/2011 - 02/2003
3	SteroidsIBA 01/2022 - 01/2008
3	fibroblast growth factor 21IBA 12/2021 - 12/2018
3	empagliflozinIBA 11/2021 - 01/2017
3	Growth Hormone (Somatotropin)IBA 03/2021 - 09/2011
3	Endothelin-1 (Endothelin 1)IBA 06/2011 - 11/2007
2	Sodium Chloride FDA LinkGeneric 01/2022 - 10/2021
2	dulaglutideIBA 01/2022 - 10/2021
2	ProlactinIBA 12/2020 - 10/2003
2	Glucagon-Like Peptide 1 (GLP 1)IBA 11/2020 - 07/2019
2	InterleukinsIBA 07/2020 - 01/2017
2	Endothelins (Endothelin)IBA 01/2020 - 08/2008
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 06/2019 - 01/2018
2	AndrogensIBA 01/2019 - 01/2018
2	Thyroid HormonesIBA 01/2019 - 04/2011
2	MineralocorticoidsIBA 12/2018 - 01/2018
2	trimethyloxamine (trimethylamine N-oxide)IBA 01/2018 - 12/2016
2	SaltsIBA 01/2018 - 01/2017

Therapy/Procedure

37	Therapeutics 11/2021 - 10/2003
8	Length of Stay 01/2022 - 07/2007
8	Critical Care (Surgical Intensive Care) 01/2018 - 09/2006
5	Patient Readmission 01/2021 - 09/2016
2	Artificial Respiration (Mechanical Ventilation) 03/2021 - 04/2016